2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $1.3B | $1.3B | $1.4B | $1.3B | $1.4B |
Cost of Revenue | $0 | $0 | $0 | $0 | -$255M |
Gross Profit | $1.3B | $1.3B | $1.4B | $1.3B | $1.7B |
Gross Profit % | 100% | 100% | 100% | 100% | 118% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$45M | $463M | $524M | $393M | $0 |
Dep. & Amort. | $50M | $46M | $46M | $46M | $0 |
Def. Tax | -$21M | $10M | -$22M | $14M | $4.3M |
Stock Comp. | $21M | $22M | $23M | $25M | $0 |
Chg. in WC | -$283M | $80M | $302M | -$96M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $1.9B | $4.2B | $888M | $1.2B | $575M |
ST Investments | $1.3B | $3.8B | $324M | $4.9B | $5.2B |
Cash & ST Inv. | $3.2B | $8.1B | $6.4B | $6.1B | $5.7B |
Receivables | $0 | $0 | $0 | $215M | $162M |
Inventory | -$2B | -$4.4B | -$1.1B | $0 | $0 |
Hancock Whitney reported strong Q1 2025 results, with 1.41% ROA, continued NIM expansion (up 2 bps to 3.43%), and total risk-based capital of 16.39%; net income was $120M ($1.38/share), up 10% YoY, and PPNR up 6% YoY.
Fee income guidance for 2025 was raised to 9-10% growth YoY (two-thirds from the Sable Trust acquisition, one-third from core businesses), while expense growth guidance remains at 4-5% YoY, including Sable; efficiency ratio expected between 54-56%.
Loan balances declined by $201M in Q1 due to large healthcare and commercial payoffs, but low single-digit loan growth is expected for full-year 2025, weighted to the second half; new hires are expected to drive ~15% of loan growth.
Deposit balances fell $298M in Q1 due to seasonal public fund outflows, but DDA balances increased and the DDA mix remained stable at 36%; $5.5B in CDs will reprice lower through 2025, supporting further NIM expansion even with three anticipated Fed rate cuts.
Capital return remains a priority: 350,000 shares repurchased in Q1 and dividend increased to $0.45/share (up 50% YoY); CET1 ratio at 14.51%, tangible common equity at 10.01%; share repurchases expected to continue at current or higher levels through 2025.